Breaking News Instant updates and real-time market news.

BOLD

Audentes Therapeutics

$27.20

-2.67 (-8.94%)

07:29
10/12/18
10/12
07:29
10/12/18
07:29

Audentes Therapeutics price target lowered to $33 from $40 at H.C. Wainwright

H.C. Wainwright analyst Debjit Chattopadhyay lowered his price target for Audentes Therapeutics to $33 after the company closed another secondary offering at $29 per share, which he notes represents a 17% discount to the January offering, which diluted shareholders by about 14%. The latest offering "leaves more than a sour taste in our mouths," Chattopadhyay tells investors in a research note. He believes Audentes had "no dire need to access the capital markets" and finds the timing and pricing of the offering "to be a little suspect." However, Chattopadhyay keeps a Buy rating on Audentes Therapeutics.

  • 11

    Oct

BOLD Audentes Therapeutics
$27.20

-2.67 (-8.94%)

10/05/18
PIPR
10/05/18
NO CHANGE
PIPR
Overweight
Piper remain buyers of Audentes after update on AT132
Piper Jaffray analyst Christopher Raymond said he remains a buyer of Audentes Therapeutics after the company announced new interim data from ASPIRO, the Phase 1/2 clinical trial of AT132 for the treatment of X-linked Myotubular Myopathy. Significant improvements in respiratory function continued for all patients in Cohort 1 and across the board CHOP-INTEND scores tended to improve for most patients, Raymond tells investors. The analyst, who thinks the XLMTM program has become "increasingly derisked," maintains an Overweight rating on Audentes shares.
10/08/18
MZHO
10/08/18
NO CHANGE
Target $45
MZHO
Buy
Audentes data met best-case scenario, says Mizuho
Mizuho analyst Difei Yang says the Phase 1/2 clinical trial of AT132 for the treatment of XLMTM reported Friday by Audentes Therapeutics were "impressive" and met her best-case scenario expectations. Cohort one patients showing continued improvements out to week 48 and the initial cohort two patient showing rapid initial improvement at week four, Yang tells investors in a research note. Further, the safety profile remains "highly encouraging" and discussions with regulators are expected to begin in Q4, the analyst adds. She reiterates a Buy rating on Audentes with a $45 price target.
10/09/18
GUGG
10/09/18
INITIATION
GUGG
Neutral
Audentes Therapeutics initiated with a Neutral at Guggenheim
10/09/18
GUGG
10/09/18
INITIATION
GUGG
Neutral
Audentes Therapeutics initiated with a Neutral at Guggenheim
Guggenheim analyst Whitney Ijem initiated Audentes Therapeutics with a Neutral rating, saying that at current levels they believe the potential revenues are already reflected.

TODAY'S FREE FLY STORIES

USAT

USA Technologies

$4.10

0.18 (4.59%)

07:39
02/21/19
02/21
07:39
02/21/19
07:39
Hot Stocks
USA Technologies partners with G&J Marketing and Sales »

USA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADIL

Adial Pharmaceuticals

$3.38

-0.21 (-5.85%)

07:39
02/21/19
02/21
07:39
02/21/19
07:39
Syndicate
Adial Pharmaceuticals 3.7M share Spot Secondary priced at $3.25 »

Maxim acted as lead book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPZ

Domino's Pizza

$278.08

-1.36 (-0.49%)

07:38
02/21/19
02/21
07:38
02/21/19
07:38
Hot Stocks
Breaking Hot Stocks news story on Domino's Pizza »

Domino's Pizza down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 14

    Mar

EME

Emcor

$68.82

0.665 (0.98%)

07:37
02/21/19
02/21
07:37
02/21/19
07:37
Earnings
Emcor reports Q4 EPS $1.38, consensus $1.35 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

RGEN

Repligen

$58.99

-0.55 (-0.92%)

07:36
02/21/19
02/21
07:36
02/21/19
07:36
Earnings
Repligen sees FY19 adj. EPS 81c-86c, consensus 85c »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WIX

Wix.com

$111.18

-14.52 (-11.55%)

07:36
02/21/19
02/21
07:36
02/21/19
07:36
Recommendations
Wix.com analyst commentary  »

Wix.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 12

    Mar

  • 18

    Mar

ROCK

Gibraltar Industries

$39.11

0.2 (0.51%)

07:36
02/21/19
02/21
07:36
02/21/19
07:36
Earnings
Gibraltar Industries sees FY19 adjusted EPS $2.40-$2.55, consensus $2.40 »

Sees revenue in excess of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

DPZ

Domino's Pizza

$278.08

-1.36 (-0.49%)

07:36
02/21/19
02/21
07:36
02/21/19
07:36
Hot Stocks
Domino's Pizza raises quarterly dividend 18% to 65c per share »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 14

    Mar

RGEN

Repligen

$58.99

-0.55 (-0.92%)

07:35
02/21/19
02/21
07:35
02/21/19
07:35
Earnings
Repligen reports Q4 adj. EPS 21c, consensus 21c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

F

Ford

$8.94

0.115 (1.30%)

, EBAY

eBay

$36.73

-0.32 (-0.86%)

07:35
02/21/19
02/21
07:35
02/21/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

F

Ford

$8.94

0.115 (1.30%)

EBAY

eBay

$36.73

-0.32 (-0.86%)

DWDP

DowDuPont

$56.25

1.65 (3.02%)

HAL

Halliburton

$32.29

0.59 (1.86%)

BHC

Bausch Health

$24.06

-1.11 (-4.41%)

DATA

Tableau

$126.99

0.05 (0.04%)

MLCO

Melco Resorts & Entertainment

$23.40

1.2 (5.41%)

NOG

Northern Oil and Gas

$2.56

0.04 (1.59%)

GOGO

Gogo

$4.26

0.16 (3.90%)

EXP

Eagle Materials

$77.91

1.24 (1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 03

    Mar

  • 04

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 12

    Mar

  • 12

    Mar

  • 13

    Mar

  • 18

    Mar

  • 19

    Mar

  • 25

    Apr

  • 15

    May

  • 22

    May

  • 28

    May

  • 24

    Jul

  • 23

    Oct

07:35
02/21/19
02/21
07:35
02/21/19
07:35
General news
Breaking General news story  »

Atlanta Federal Reserve…

DPZ

Domino's Pizza

$278.08

-1.36 (-0.49%)

07:34
02/21/19
02/21
07:34
02/21/19
07:34
Hot Stocks
Breaking Hot Stocks news story on Domino's Pizza »

Domino's Pizza…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 14

    Mar

ROCK

Gibraltar Industries

$39.11

0.2 (0.51%)

07:34
02/21/19
02/21
07:34
02/21/19
07:34
Earnings
Gibraltar Industries sees Q1 adjusted EPS 27c-32c, consensus 32c »

Sees revenue $218M-$224M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

ACRGF

Acreage Holdings

$0.00

(0.00%)

07:33
02/21/19
02/21
07:33
02/21/19
07:33
Initiation
Acreage Holdings initiated  »

Acreage Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPZ

Domino's Pizza

$278.08

-1.36 (-0.49%)

07:33
02/21/19
02/21
07:33
02/21/19
07:33
Hot Stocks
Domino's Pizza affirms 3-5 year outlook »

The company reaffirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 14

    Mar

ATKR

Atkore

$24.17

0.23 (0.96%)

07:33
02/21/19
02/21
07:33
02/21/19
07:33
Initiation
Atkore initiated  »

Atkore initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROCK

Gibraltar Industries

$39.11

0.2 (0.51%)

07:32
02/21/19
02/21
07:32
02/21/19
07:32
Earnings
Gibraltar Industries reports Q4 adjusted EPS 47c, consensus 40c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

APHA

Aphria

$10.16

0.47 (4.85%)

07:31
02/21/19
02/21
07:31
02/21/19
07:31
Initiation
Aphria initiated  »

Aphria initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPZ

Domino's Pizza

$278.08

-1.36 (-0.49%)

07:31
02/21/19
02/21
07:31
02/21/19
07:31
Earnings
Domino's Pizza reports Q4 adjusted EPS $2.62, consensus $2.69 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 14

    Mar

ADI

Analog Devices

$106.81

2.6 (2.50%)

, TXN

Texas Instruments

$107.93

0.66 (0.62%)

07:31
02/21/19
02/21
07:31
02/21/19
07:31
Recommendations
Analog Devices, Texas Instruments analyst commentary  »

Analog Devices price…

ADI

Analog Devices

$106.81

2.6 (2.50%)

TXN

Texas Instruments

$107.93

0.66 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 13

    Mar

  • 09

    Apr

  • 28

    May

ADSK

Autodesk

$159.86

-0.76 (-0.47%)

07:30
02/21/19
02/21
07:30
02/21/19
07:30
Recommendations
Autodesk analyst commentary  »

Autodesk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

TGE

Tallgrass Energy

$23.56

-0.145 (-0.61%)

07:30
02/21/19
02/21
07:30
02/21/19
07:30
Downgrade
Tallgrass Energy rating change  »

Tallgrass Energy …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$45.12

0.3 (0.67%)

, ZNGA

Zynga

$5.04

-0.06 (-1.18%)

07:30
02/21/19
02/21
07:30
02/21/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

KO

Coca-Cola

$45.12

0.3 (0.67%)

ZNGA

Zynga

$5.04

-0.06 (-1.18%)

AAOI

Applied Optoelectronics

$14.62

-0.305 (-2.04%)

TSM

TSMC

$39.01

0.54 (1.40%)

FITB

Fifth Third

$27.92

0.405 (1.47%)

HRL

Hormel Foods

$43.13

-0.18 (-0.42%)

PWR

Quanta Services

$36.60

0.925 (2.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 03

    Mar

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

TLRY

Tilray

07:29
02/21/19
02/21
07:29
02/21/19
07:29
Initiation
Tilray initiated  »

Tilray initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 18

    Mar

A

Agilent

$78.56

1.08 (1.39%)

07:29
02/21/19
02/21
07:29
02/21/19
07:29
Recommendations
Agilent analyst commentary  »

Agilent price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.